No Fertilisation After ICSI: What Should the Embryology Report Explain?

Ask for the number of follicles monitored, eggs retrieved, mature eggs available for injection, eggs actually injected and eggs showing normal fertilisation. These are different stages, and a poor result at one stage should not be explained by a problem at another without evidence. Embryologists may describe two pronuclei as a normal early fertilisation sign; other appearances need interpretation in the laboratory context. Request the original embryology sheet and a plain-language explanation rather than a summary that simply says the cycle failed.

Fertilisation can be influenced by egg maturity, sperm viability and laboratory handling, among other issues. Even when ICSI is used, successful fertilisation is not certain. One report cannot prove that “the egg was bad” or “the sperm was bad.” Consider age, stimulation response, previous treatment, semen or surgically retrieved sperm findings and any relevant medical history. A repeat semen analysis or specialist male-fertility review may be reasonable in selected cases, but broad genetic or immune panels are not automatically indicated.

Sometimes review of follicle sizes, trigger timing and egg maturity suggests a specific question for the treating doctor. In other cases, the retrieved eggs were mature and the reason for absent fertilisation remains unclear. Ask what evidence supports a different drug dose, trigger strategy or laboratory method. Multiple simultaneous changes make it difficult to learn from the next cycle. The doctor and embryologist should be able to name the problem they are trying to address and acknowledge where evidence is uncertain.

Some centres discuss assisted oocyte activation or other specialist methods after total fertilisation failure. Suitability, evidence, safety and regulatory considerations require expert review and clear consent; these should not be presented as standard guaranteed solutions. If another retrieval is planned, ask for a contingency pathway if few mature eggs are obtained or fertilisation again fails. A second opinion may be more useful than immediately purchasing a list of optional techniques without understanding what the first laboratory recorded.

HomeIVF is a doctor-led approach to coordinating fertility and IVF care with fewer unnecessary clinic visits. In a complex male-factor pathway, a secure review of original semen, hormone and previous treatment records may be a useful first consultation. Selected prescribed blood collection, medication teaching, injection support or teleconsultation may be possible only when medical suitability, trained support and local serviceability are confirmed. Male examinations, surgical sperm retrieval, laboratory sperm preparation, ovarian scans, egg retrieval, embryology and embryo transfer remain at qualified facilities. A coordinator should never replace the judgement of the andrologist, embryologist or treating fertility doctor.

A useful care plan identifies who interprets the semen results, who assesses ovarian response, and which specialist can perform any procedure under consideration. Ask the embryology laboratory about practical dependencies before starting stimulation: sperm availability, consent, specimen identification, and contingency steps if retrieval or fertilisation does not proceed as hoped. Reports may travel securely even when patients should not. Having the right records available in advance may save appointments; it does not make physical examinations, ultrasounds or operating-room procedures optional.

Bring original reports for both partners, including dates, units, reference ranges and laboratory names; list medicines, earlier pregnancies and previous fertility treatment. Ask which assessment will take priority, who coordinates the two specialists and which result could change the timing of stimulation. If a consent-based donor option is discussed, request time to consider personal, genetic and legal issues without pressure. Make a written contingency plan for the possibility that no eggs, sperm or transferable embryos are available. Such planning is not pessimism; it helps people consent to procedures with eyes open.

A written estimate should separate assessment, hormones and imaging, possible sperm retrieval, anaesthesia, storage, egg stimulation, laboratory ICSI and eventual transfer. Ask what is billed when retrieval finds no sperm or an IVF cycle produces no transferable embryo. Optional genetic investigations need their own rationale and informed consent. The financial plan should also reflect follow-up by more than one specialist. Avoid interpreting an advertised price for ICSI as a promise that it includes surgical sperm retrieval or future transfer.

Every invasive retrieval, anaesthetic and ovarian stimulation needs informed consent and a facility-based safety plan. Severe or worsening pain, fainting, heavy bleeding, breathing difficulty or significant illness during treatment requires prompt clinical assessment; seek local emergency care for severe symptoms. Home visits should not delay urgent help. If conception occurs, follow the pregnancy team’s advice rather than interpreting the earliest test without context. Outcomes remain uncertain, even with specialist treatment and excellent coordination.

Ask for a short letter recording the interpretation of both partners’ tests, remaining uncertainties, the agreed next step and alternatives if the proposed procedure does not produce usable material. This helps another specialist understand the choices without repeating sensitive conversations. If the advice differs between clinicians, ask them to explain the disagreement together. The couple should have time to decide without blame or claims that a single treatment can overcome every limitation.